-
EP1648513
European procedure
Extract from the Register of European Patents
EP Citations: EP1648513
| Cited in | International search | Type: | Patent literature | Publication No.: | EP0576093
[A] (AETSRN [FR], et al) [A] 1-9,13-15 * page 3, line 11 - line 37 *; | Type: | Patent literature | Publication No.: | WO0177181
[X] (LAB FRANCAIS DU FRACTIONNEMENT [FR], et al) [X] 1-9,13-15 * page 35, line 23 - page 37, line 14; claims 1-32 *; | Type: | Non-patent literature | Publication information: | [DX] - KUMPEL B M ET AL, "Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of FcgammaRIIIa (CD16).", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, (200304), vol. 132, no. 1, ISSN 0009-9104, pages 81 - 86, XP001193742 [DX] 1-9,13-15 * the whole document * | DOI: | http://dx.doi.org/10.1046/j.1365-2249.2003.02119.x | Type: | Non-patent literature | Publication information: | [DA] - SHINKAWA T ET AL, "The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (20030131), vol. 278, no. 5, ISSN 0021-9258, pages 3466 - 3473, XP002965857 [DA] 1-9,13-15 * page 3466, column L * * page 3471, column L, paragraph LAST - page 3473, column L, paragraph 1 * | DOI: | http://dx.doi.org/10.1074/jbc.M210665200 | Type: | Non-patent literature | Publication information: | [DA] - UMANA P ET AL, "ENGINEERED GLYCOFORMS OF AN ANTINEUROBLASTOMA IGG1 WITH OPTIMIZED ANTIBODY-DEPENDENT CELLULAR CYTOTOXIC ACTIVITY", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, (199902), vol. 17, ISSN 1087-0156, pages 176 - 180, XP002921620 [DA] 1-9,13-15 * page 176, column L, paragraph 2 - column R, paragraph 2; figure 1 * | DOI: | http://dx.doi.org/10.1038/6179 | Type: | Non-patent literature | Publication information: | [DA] - SHIELDS R L ET AL, "Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcgammaRIII and antibody-dependent cellular toxicity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (20020726), vol. 277, no. 30, ISSN 0021-9258, pages 26733 - 26740, XP002964542 [DA] 1-9,13-15 * the whole document * | DOI: | http://dx.doi.org/10.1074/jbc.M202069200 | Type: | Non-patent literature | Publication information: | [DX] - CARTRON GUILLAUME ET AL, "Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene", BLOOD, & 43RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, PART 1; ORLANDO, FLORIDA, USA; DECEMBER 07-11, 2001, (20011116), vol. 98, no. 11 Part 1, ISSN 0006-4971, page 602a, XP001193741 [DX] 1-15 * the whole document * | DOI: | http://dx.doi.org/10.1182/blood.V99.3.754 | Type: | Non-patent literature | Publication information: | [X] - CROWE J S ET AL, "HUMANIZED MONOCLONAL ANTIBODY CAMPATH-1H MYELOMA CELL EXPRESSION OF GENOMIC CONSTRUCTS NUCLEOTIDE SEQUENCE OF CDNA CONSTRUCTS AND COMPARISON OF EFFECTOR MECHANISMS OF MYELOMA AND CHINESE HAMSTER OVARY CELL-DERIVED MATERIAL", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, OXFORD, GB, (1992), vol. 87, no. 1, ISSN 0009-9104, pages 105 - 110, XP008034008 [X] 1,6-10,12-15 * page 106, column L, paragraph 2 * * page 107, column R, line 10 - line 56 * | Type: | Non-patent literature | Publication information: | [X] - LIFELY M R (REPRINT) ET AL, "Glycosylation and biological-activity of CAMPATH-1H expressed in different cell-lines and grown under different culture conditions", GLYCOBIOLOGY, IRL PRESS,, GB, (199512), vol. 5, no. 8, ISSN 0959-6658, pages 813 - 822, XP002096118 [X] 1,6-10,12-15 * the whole document * | DOI: | http://dx.doi.org/10.1093/glycob/5.8.813 | Cited in | Examination | Type: | Patent literature | Publication No.: | EP1176195
| Type: | Non-patent literature | Publication information: | - N. I. OLOVNIKOVA ET AL, "Effect of Producer Cell Line on Functional Activity of Anti-D Monoclonal Antibodies Destined for Prevention of Rhesus Sensitization", BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, (20090401), vol. 147, no. 4, doi:10.1007/s10517-009-0516-0, ISSN 0007-4888, pages 448 - 452, XP055000368 | DOI: | http://dx.doi.org/10.1007/s10517-009-0516-0 | Type: | Non-patent literature | Publication information: | - SHIELDS R L ET AL, "Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcgammaRIII and antibody-dependent cellular toxicity", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (20020726), vol. 277, no. 30, doi:10.1074/JBC.M202069200, ISSN 0021-9258, pages 26733 - 26740, XP002964542 | DOI: | http://dx.doi.org/10.1074/jbc.M202069200 | Type: | Non-patent literature | Publication information: | - GUILE G ET AL, "Rapid High-Resolution High-Performance Liquid Chromatographic Method for Separating Glycan Mixtures and Analyzing Oligosaccharide Profiles", ANALYTICAL BIOCHEMISTRY, (1996), vol. 240, pages 210 - 226 | Type: | Non-patent literature | Publication information: | - DWEK R.A ET AL, "Glycobiology: "The function of sugar in the IgG molecule"", J. ANAT., (1995), vol. 187, pages 279 - 292 | Type: | Non-patent literature | Publication information: | - HOLLAND M. ET AL, "Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis", CLIN EXP IMMUNOL, (2002), vol. 129, pages 183 - 190 | Type: | Non-patent literature | Publication information: | - CHANG K. H. ET AL., "Quantitative analysis of oligosaccharide structure of glycoproteins", BIOTECHNOL. BIOPROCESS ENG., (2000), vol. 5, pages 136 - 140 | Type: | Non-patent literature | Publication information: | - CHARLWOOD J. ET AL, "Characterization of the lycosylation profiles of alzheimer's beta-secretase protein Asp-2 expressed in a variety of cell lines", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2001), vol. 276, no. 20, pages 16739 - 16748 | Cited in | by applicant | Type: | Non-patent literature | Publication information: | - CARTRON G; DACHEUX L; SALLES G; SOLAL-CELIGNY P; BARDOS P; COLOMBAT P; WATIER H, "Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene", BLOOD, (20020201), vol. 99, no. 3, pages 754 - 8 |